Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Murakami (Sendai, Japan), T. Tamada (Sendai, Japan), D. Saigusa (Sendai, Japan), M. Nara (Yurihonjo, Japan), E. Miyauchi (Sendai, Japan), H. Aritake (Sendai, Japan), S. Gamo (Sendai, Japan), H. Sugiura (Sendai, Japan), Y. Yatomi (Tokyo, Japan), M. Ichinose (Sendai, Japan). The clinical significance of plasma and urine lysophospholipids-producing enzymes in patients with sarcoidosis. 1080

Member's Comments

No comment yet.

Related content which might interest you: The evaluation of serum biomarkers in patients with sarcoidosis: Can visfatin be a new biomarker for sarcoidosis? Source: International Congress 2017 – Rare diseases Year: 2017 The relationship between level of C-reactive protein in blood serum and clinical manifestations of the disease in patients with pulmonary tuberculosis Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010 The significance of serum angiotenzin converting enzyme in diagnosing sarcoidosis Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 Pleural fluid and plasma D-dimer levels tuberculous pleurisy: the diagnostic value and relation with clinical parameters Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections Year: 2009 There are no correlations between the level of serum antichlamidia antibodies and clinical course of sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 539s Year: 2006 Is there any clinical application for determining the serum cytokines profile in sarcoid patients? Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis Year: 2008 Serum lipid levels in patients with bronchiectasis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Gender differences in plasma biomarkers levels in patients with COPD Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Serum biomarkers in SSc-ILD: association with presence, severity and prognosis Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 The clinical significance of plasma DNA quantification in NSCLC Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 The predictive prognostic role of elevated blood d-dimer and blood lactate in severe sepsis patients Source: Annual Congress 2009 - Acute lung injury and biomarkers Year: 2009 Serum KL-6 and SP-D as useful clinical indicators of interstitial changes and pulmonary functional abnormality in patients with Sjogren's syndrome Source: Eur Respir J 2001; 18: Suppl. 33, 367s Year: 2001 Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis? Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004 Lipid metabolite levels recovered from BAL fluid correlate with lung function of COPD patients and controls Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008 The prognostic significance of different clinical, radiological and laboratory parameters in sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 46s Year: 2003 The relationship between the clinical symptoms, BALF cells and indices of respiratory function in patients with newly diagnosed sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 534s Year: 2004 Discrepant elevation of sIL-2R levels in sarcoidosis patients with renal insufficiency Source: Eur Respir J 2015; 46: 277-280 Year: 2015 Stability of serum biomarkers and their associations with clinical outcomes in COPD patients and controls: a longitudinal study Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Significance of abnormal autoantibodies in patients presenting with IPF Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Clinical significance of serum adipokines levels in lung cancer Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009